Prototypes of a portable test for Zika virus and a range of other diseases, using just a microchip plugged into a smartphone, may be available by the end of 2016.
Zika – a rapidly-spreading, mosquito-borne disease – doesn’t always show symptoms and currently has no treatment or vaccine.
The new test could be performed from the comfort of the patient’s own home according to Professor Kirill Alexandrov from the Institute for Molecular Bioscience (IMB) at The University of Queensland.
Blood tests using nanoparticles carrying molecules which can detect breast cancer biomarkers could save millions of lives and open the way to mass screening for many cancers.
Prof. Matt Trau, of the Australian Institute for Bioengineering & Nanotechnology at the University of Queensland, and his team are using a combination of nanotechnology and molecular biology in the project, funded by a five-year $5 million grant from the National Breast Cancer Foundation.